The Food and Drug Administration announced the approval of Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is caused by Leishmania, a parasite transmitted to humans through sand fly bites.
Purdue Pharma recently announced that a Phase 3 study of an investigational extended‐release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once‐daily analgesic agent experienced statistically significant reduction in pain compared with placebo.
Procter & Gamble on Thursday announced that its brand Febreze has partnered with the Weather Channel’s newest anchor Sam Champion, host of “America’s Morning Headquarters with Sam Champion,” to educate consumers on the connection between the outdoor pollen count and allergens found in the home.
Meijer on Thursday announced added features to its mPerks program that allows customers to store digital receipts from purchases in a single place and details exactly how much they've saved by shopping at Meijer locations.
A study published earlier this week in the journal Pediatrics determined that the probiotic Lactobacillus reuteri helped substantially reduce episodes of diarrhea and respiratory tract infections among children in a daycare setting.